Variant report
Variant | nsv963772 |
---|---|
Chromosome Location | chr2:212162262-212163802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ERBB4-1 | chr2:212163666-212163914 | NONHSAT076685 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377750677 | chr2:212162277-212162278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147955030 | chr2:212162285-212162286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373402025 | chr2:212162306-212162307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114009721 | chr2:212162460-212162461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367772821 | chr2:212162540-212162541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10199316 | chr2:212162567-212162568 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs554480368 | chr2:212162597-212162598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567980590 | chr2:212162603-212162604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7605116 | chr2:212162678-212162679 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs182824400 | chr2:212162705-212162706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553684107 | chr2:212162725-212162726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141907942 | chr2:212162745-212162746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539566221 | chr2:212162749-212162750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150450177 | chr2:212162823-212162824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575943047 | chr2:212162905-212162906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79633228 | chr2:212162925-212162926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145371914 | chr2:212162930-212162931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187105261 | chr2:212162940-212162941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113140001 | chr2:212162980-212162981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191661188 | chr2:212162995-212162996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149196002 | chr2:212163037-212163038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532400789 | chr2:212163038-212163039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552670823 | chr2:212163039-212163040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562828694 | chr2:212163076-212163077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531418513 | chr2:212163098-212163099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367689380 | chr2:212163099-212163100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528024385 | chr2:212163127-212163128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4550605 | chr2:212163141-212163142 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs533797297 | chr2:212163148-212163149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547370072 | chr2:212163186-212163187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138592470 | chr2:212163195-212163196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530413134 | chr2:212163213-212163214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183116579 | chr2:212163217-212163218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556239350 | chr2:212163266-212163267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571071497 | chr2:212163268-212163269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369887906 | chr2:212163282-212163283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111904578 | chr2:212163341-212163342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375223859 | chr2:212163351-212163352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555158829 | chr2:212163371-212163372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575074865 | chr2:212163372-212163373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540970140 | chr2:212163397-212163398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187611570 | chr2:212163410-212163411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577205135 | chr2:212163424-212163425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7606138 | chr2:212163426-212163427 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs192630591 | chr2:212163429-212163430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113065264 | chr2:212163442-212163443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547991419 | chr2:212163451-212163452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10497932 | chr2:212163453-212163454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs113381943 | chr2:212163480-212163481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535479750 | chr2:212163516-212163517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212159600-212166800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr2:212163600-212164000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |